Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer

Suleiman Massarweh, Jessica Moss, Chi Wang, Edward Romond, Stacey Slone, Heidi Weiss, Rouzan G. Karabakhtsian, Dana Napier, Esther P. Black

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences